Disclosure 0000907654-26-000106-5

SEC FORM 4

$160,272.29

Oruka Therapeutics, Inc. (ORKA)

Sale of 1,958 shares at $81.8551 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0000907654-26-000106 · filed 2026-10-13 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Oruka Therapeutics, Inc. (ORKA)." Disclosed 2026-10-13. https://desqlong.com/cards/0000907654-26-000106-5 (retrieved 2026-10-14).